Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum FormerXBC Inc XEBEQ

Xebec Adsorption Inc designs, engineers, and manufactures products that are used for purification, separation, dehydration, and filtration equipment for gases and compressed air. The company operates in three reportable segments: Systems, Corporate and other, and Support. Its product lines are natural gas dryers for natural gas refueling stations, compressed gas filtration, biogas purification,... see more

GREY:XEBEQ - Post Discussion

FormerXBC Inc > Legacy
View:
Post by Gann999 on May 13, 2022 8:37am

Legacy

The legacy contracts impacted this quarter but they announced prior to results that they had entered the startup and commission phase so one can gather from that that the majority of the impact from the end of legacy has now been incurred and moving forward we will likely see 50 plus million revenue and margins improved let's start with 17 percent as benchmark but likely better.
Comment by Takis on May 13, 2022 10:59am
This post is not getting enough love. It's dead on. Margins will improve going forward.
Comment by Gann999 on May 13, 2022 11:10am
Positive takes fall on deaf ears in these times unfortunately.
Comment by Ciao on May 13, 2022 11:41am
Ex BGX legacy issues, margins were stated by Stephane as being 17%.
Comment by Gann999 on May 13, 2022 11:47am
Yes but the point is they will deliver more than 2 of the new Biostream units which by the way are lower margin due to learning curve so so 6 in q2 boosts revenue by 10 million at least on better than 17 percent margins a lot of people are focusing on the negative and ignoring this positive fact.
Comment by kulewater on May 13, 2022 12:02pm
The issue is that they had stated to be passed all the legacy overruns by Q4 last year. Now its 12 months more.  Q4 had positive EPS, back into the red this Q for some reason. The optics arent great. And the CFO isnt inspiring confidence.
Comment by Gann999 on May 13, 2022 12:12pm
Absolutely agree with you kulewater it's disgusting what they did absolutely unacceptable. It appears we as shareholders were lied to and deceived with a one off accounting trick in q4 that they are backing off on now in q1 citing covid issues in Shanghai when last q they paraded it as a great accomplishment and success. And then now we are stuck with legacy issues still although I would argue ...more  
Comment by LongoGlueStick on Oct 15, 2022 5:31pm
Kulewater was another incessant, know it all Xebec pumper. He seems to have disappeared from Stockhouse as well. At least in this post, he seems to be admitting that Xebec is a disaster.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities